StopDown
PopVax logo
Launch · 12 November 2026PopVaxHyderabad mRNA biotechpopvax.com ↗

PopVax builds open personalised cancer vaccine

By · Editor ·

HyderabadFounded 2021
  • PopVax is a Hyderabad biotech company that designs mRNA vaccines, with its own RNA Foundry for making them
  • It is making a personalised vaccine for a 34-year-old pancreatic cancer patient, designed from the genetic sequence of his tumour
  • Scientists worldwide are invited to review and improve the design in the open before any manufacturing starts

What happened

  • PopVax is building a personalised cancer vaccine.
  • The patient is a 34-year-old with pancreatic cancer.
  • The design comes from tumour sequencing.
  • Outside experts can review the design before manufacture.
  • Production happens at the RNA Foundry in Hyderabad.

Why it matters

  • Tumours carry different mutations in different patients.
  • A tailored vaccine aims to train the immune system to target those mutations.
  • The open-review approach lets global researchers contribute.

The business

  • PopVax develops mRNA vaccines in Hyderabad.
  • It runs an RNA Foundry that designs and makes such vaccines.
  • Its pipeline is open to scientific review.

The founders

Soham Sankaran

Founder
in

What happens next

  • Manufacturing begins after the open design review.

Words to know

mRNA
A molecule that tells cells how to make a specific protein.

The numbers around it

Healthcare & Life Sciences in November 2026: 3 rounds with a disclosed amount, $5.3 million in all; the biggest was Venomics AI ($2.7M). Every sector this year →

Read it as a card in the app

All startup news on 12 November 2026 →

Is this PopVax? Get your “Featured on StopDown” badge →